<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

New Update: Healthcare Costs Increasing by Over 60% in Some States. Will you be impacted?

Learn More

For Merck Employees: CHIPs and Science Act Aims to Preserve U.S. Technology Edge

image-table

Healthcare Provider Update: Healthcare Provider for Merck Merck & Co., Inc., commonly known as Merck, is a global leader in the healthcare sector, renowned for its innovative pharmaceuticals, vaccines, and biologic therapies. As a prominent healthcare provider, Merck delivers a wide array of health solutions targeting various health conditions, particularly in areas such as immunology, oncology, and infectious diseases. Potential Healthcare Cost Increases in 2026 In 2026, healthcare costs are projected to rise significantly, primarily driven by the anticipated expiration of enhanced federal premium subsidies associated with the Affordable Care Act (ACA) and growing medical expenses. Faced with an average premium increase of 18%, healthcare consumers may experience out-of-pocket costs climbing by over 75%. This situation is exacerbated by surging medical care prices, as hospitals and providers seek to balance inflationary pressures while maintaining profitability. As a result, many individuals may find themselves priced out of adequate health coverage, prompting essential discussions on the need for policy interventions. Click here to learn more

Those in Merck employees are inquiring about The CHIPs and Science Act of 2022. This act signed into law on August 9, is a bipartisan legislation package that provides more than $50 billion in direct financial assistance for semiconductor companies to increase U.S.-based design, research, and manufacturing capabilities. In addition, the legislation authorizes nearly $170 billion in federal funding over five years for research and development (R&D) programs in strategic areas of science and technology, such as artificial intelligence, quantum computing, wireless communications, clean energy, and precision agriculture.


For those in Merck considering it's repercussions, in a significant expansion of industrial policy, federal subsidies are being offered to help reduce the nation's reliance on semiconductors produced mostly overseas and forge a more resilient supply chain. The largest-ever U.S. investment in public R&D (in dollar terms) is intended to fuel technological innovation more broadly and help ensure U.S. economic competitiveness — primarily against China — in the future.

CHIP independence
If you are an employee of Merck and interested in allocating your money into technology, you may benefit from understanding about chip independence. A semiconductor (also called a microchip or chip) is a tiny set of electronic circuits on a small piece of silicon or germanium. A single advanced chip may have more than 50 billion microscopic transistors. Chips power nearly all electronic devices used by consumers, including computers, mobile phones, vehicles, and medical devices. The crucial role that chips play in the economy became more evident during the pandemic, when a surge in demand kicked off a global shortage that disrupted supply chains and later helped drive up inflation. A dependable supply of chips is also important for national security reasons — the U.S. Department of Defense purchases 1.9 billion semiconductors annually for its communications and weapons systems. 1

U.S. semiconductor companies tend to be leaders in chip research, development, and design, but for cost reasons, manufacturing has often been outsourced to foundries in southeast Asia. Despite that, Those in Merck should understand that the United States currently accounts for only about 10% of global chip manufacturing capacity, and it doesn't produce any of the most advanced chips. About two-thirds of the world's advanced chips are made in Taiwan, an island roughly 100 miles from mainland China. 2

Taiwan's manufacturing dominance is viewed as a potential economic and national security threat due to ongoing geopolitical tensions between the United States and China. Taiwan considers itself independent, although China claims it as part of its territory.

When accounting for that information, those in Merck may better understand the reasoning behind the Act providing roughly $39 billion in funding (grants, loans, and loan guarantees) for the domestic construction and expansion of highly complex semiconductor fabrication facilities (called fabs) and $11 billion for chip manufacturing research and workforce development. In addition, there is a 25% tax credit for companies that invest in advanced semiconductor production in the United States. The Department of Defense will receive $2 billion to accelerate chip-related defense spinoffs, and about $1.5 billion will go to the Public Wireless Supply Chain Innovation Fund. This fund was established by previous legislation to enable the development of a secure, open-architecture, 5G broadband network that doesn't depend on Chinese hardware.


Merck employees may also benefit from understanding that companies accepting federal funds from these programs are prohibited from building or expanding advanced semiconductor facilities in China or other countries that present a national security concern.

R&D across America
An influx of almost $170 billion will support R&D in advanced and emerging technologies, with the funding divided among several federal agencies. The National Science Foundation will receive $20 billion to oversee a new directorate focused on accelerating the development of technologies critical to national security and $61 billion to support research at universities and other organizations. Another $50 billion will fund advanced energy programs within the Department of Energy. For Merck employees, understanding these cash flows may be beneficial when investing and conducting future financial planning.

The Department of Commerce will designate 20 regional technology hubs and spend $11 billion to foster innovation and help create more higher-paying tech jobs around the country. State and local governments, universities, and private industry will collaborate on new technology centers designed to help improve the economic prospects of communities that have been negatively affected by globalization.

The legislation provides about $13 billion to help improve K-12 and college education in the science, technology, engineering, and math (STEM) disciplines. NASA's funding was extended so the agency can continue space exploration, and new priorities were established, including the research required to send astronauts to Mars.

Featured Video

Articles you may find interesting:

Loading...


Economic impact
Those in Merck may benefit from understanding the economic impacts of the chip shortage when planning to invest in assets reliant on this technology. In 2020, the chip industry contributed roughly $246 billion to U.S. gross domestic product (GDP). It currently employs more than 277,000 people in 49 states and supports an additional 1.6 million U.S. jobs. A study by the Semiconductor Industry Association and Oxford Economics projected that a $50 billion federal investment in domestic chip fabs would create 185,000 temporary jobs and add nearly $25 billion to economic output each year through 2026 as new fabs are constructed. At that level of funding, a total of 10 new fabs could be constructed in the United States that would not have been built otherwise, adding 42,000 permanent semiconductor jobs to the economy. 3

Chip makers have already announced the construction of multiple new or expanded fabs in the United States, some of which were considered contingent upon the Act passing. 4  Other nations, including South Korea, Japan, and India have also passed incentives to attract semiconductor industry investments and increase domestic production, and the European Union is working on a similar initiative. 5

The Act clearly benefits the semiconductor industry directly, but most companies, and perhaps Merck, depend on computer chips or products made with them — some more heavily than others. It's estimated that chip shortages cost the global auto industry 11.3 million vehicles and $210 billion in lost revenue in 2021 and have continued to slow production in 2022.6 For similar reasons, more than 100 U.S. CEOs across a variety of sectors signed a letter urging Congress to pass the Act in order to enhance U.S. competitiveness.

1) Congressional Research Service, 2020
2) U.S. Department of Commerce, 2022
3) Semiconductor Industry Association/Oxford Economics, 2021
4) The Wall Street Journal, July 28, 2022
5) The New York Times, June 24, 2022
6) Motortrend, December 27, 2021

How does Merck's new retirement benefits program support long-term financial security for employees, particularly regarding the changes to the pension and savings plans introduced in 2013? Can you elaborate on how Merck's commitment to these plans is designed to help employees plan for retirement effectively?

Merck's New Retirement Benefits Program: Starting in 2013, Merck introduced a comprehensive retirement benefits program aimed at providing all eligible employees, irrespective of their legacy company, uniform benefits. This initiative supports Merck's commitment to financial security by integrating pension plans, savings plans, and retiree medical coverage. This approach not only aims to help employees plan effectively for retirement but also aligns with Merck’s post-merger goal of standardizing benefits across the board.

What are the key differences between the legacy pension benefits offered by Merck before 2013 and the new cash balance formula implemented in the current retirement program? In what ways do these changes reflect Merck's broader goal of harmonizing benefits across various employee groups?

Differences in Pension Formulas: Before 2013, Merck calculated pensions using a final average pay formula which typically favored longer-term, older employees. The new scheme introduced a cash balance formula, reflecting a shift towards a more uniform accumulation of retirement benefits throughout an employee's career. This change was part of Merck's broader strategy to harmonize benefits across various employee groups, making it easier for employees to understand and track their pension growth.

In terms of eligibility, how have Merck's pension and savings plans adjusted for years of service and age of retirement since the introduction of the new program? Can you explain how these adjustments might affect employees nearing retirement age compared to newer employees at Merck?

Adjustments in Eligibility: The new retirement program revised eligibility criteria for pension and savings plans to accommodate a wider range of employees. Notably, the pension benefits under the new program are designed to be at least equal to the prior benefits for services rendered until the end of 2019, provided employees contribute a minimum of 6% to the savings plan. This adjustment aids both long-term employees and those newer to the company by offering equitable benefits.

Can you describe the transition provisions that apply to legacy Merck employees hired before January 1, 2013? How does Merck plan to ensure that these provisions protect employees from potential reductions in retirement benefits during the transition period?

Transition Provisions for Legacy Employees: For employees who were part of legacy Merck plans before January 1, 2013, Merck established transition provisions that allow them to earn retirement income benefits at least equal to their current pension and savings plan benefits through December 31, 2019. This ensures that these employees do not suffer a reduction in benefits during the transition period, offering a sense of security as they adapt to the new program.

How does employee contribution to the retirement savings plan affect the overall retirement benefits that Merck provides? Can you discuss the implications of Merck's matching contributions for employees who maximize their savings under the new retirement benefits structure?

Impact of Employee Contribution to Retirement Savings: In the new program, Merck encourages personal contributions to the retirement savings plan by matching up to 6% of employee contributions. This mutual contribution strategy enhances the overall retirement benefits, incentivizing employees to maximize their savings for a more robust financial future post-retirement.

What role does Merck's Financial Planning Benefit, offered through Ernst & Young, play in assisting employees with their retirement planning? Can you highlight how engaging with this benefit changes the financial landscapes for employees approaching retirement?

Role of Merck’s Financial Planning Benefit: Offered through Ernst & Young, this benefit plays a critical role in assisting Merck employees with retirement planning. It provides personalized financial planning services, helping employees understand and optimize their benefits under the new retirement framework. Engaging with this service can significantly alter an employee’s financial landscape by providing expert guidance tailored to individual retirement goals.

How should employees evaluate their options for retiree medical coverage under the new program compared to previous offerings? What considerations should be taken into account regarding the potential costs and benefits of the retiree medical plan provided by Merck?

Options for Retiree Medical Coverage: With the new program, employees must evaluate both subsidized and unsubsidized retiree medical coverage options based on their age, service length, and retirement needs. The program offers different levels of company support depending on these factors, making it crucial for employees to understand the potential costs and benefits to choose the best option for their circumstances.

In what ways does the introduction of voluntary, unsubsidized dental coverage through MetLife modify the previous dental benefits structure for Merck retirees? Can you detail how these changes promote cost efficiency while still providing valuable options for employees?

Introduction of Voluntary Dental Coverage: Starting January 2013, Merck shifted from sponsored to voluntary, unsubsidized dental coverage through MetLife for retirees. This change aligns with Merck’s strategy to promote cost efficiency while still providing valuable dental care options, allowing retirees to choose plans that best meet their needs without company subsidy.

How can employees actively engage with Merck's resources to maximize their retirement benefits? What specific tools or platforms are recommended for employees to track their savings and retirement progress effectively within the new benefits framework?

Engaging with Merck’s Retirement Resources: Merck provides various tools and platforms for employees to effectively manage and track their retirement savings and benefits. Employees are encouraged to utilize resources like the Merck Financial Planning Benefit and online benefit portals to make informed decisions and maximize their retirement outcomes.

For employees seeking additional information about the retirement benefits program, what are the best ways to contact Merck? Can you provide details on whom to reach out to, including any relevant phone numbers or online resources offered by Merck for inquiries related to the retirement plans?

Contacting Merck for Retirement Plan Information: Employees seeking more information about their retirement benefits can contact Merck through dedicated phone lines provided in the benefits documentation or by accessing detailed plan information online through Merck's official benefits portal. This ensures employees have ready access to assistance and comprehensive details regarding their retirement planning options.

With the current political climate we are in it is important to keep up with current news and remain knowledgeable about your benefits.
Merck offers a defined benefit pension plan with a cash balance formula. Benefits are determined based on years of service and compensation. Employees can choose between a lump-sum payment or a monthly annuity upon retirement.
Operational Changes: Merck is restructuring its business to focus more on its core pharmaceuticals and vaccines segments, leading to layoffs affecting around 1,800 employees (Source: Bloomberg). Strategic Initiatives: The company aims to enhance operational efficiency and invest more in research and development. Financial Performance: Merck reported a 10% increase in net sales for Q3 2023, driven by strong demand for its COVID-19 treatments and vaccines (Source: Merck).
Merck grants RSUs that vest over time, providing shares to employees upon vesting. The company also offers stock options, allowing employees to purchase shares at a fixed price.
New call-to-action

Additional Articles

Check Out Articles for Merck employees

Loading...

For more information you can reach the plan administrator for Merck at 2000 galloping hill road Kenilworth, NJ 7033; or by calling them at 908-423-1000.

https://www.benefitsatmerck.com/wp-content/uploads/2023/09/MRK-2024-AE-mailer-L6a-092023-front-post-ltr.pdf - Page 5 https://www.horizonblue.com/merck/securecms-documents/2087/horizon-bcbs-merck-spd-2023-mpe.pdf - Page 12 https://www.merck.com/content/dam/merck/investors/financials/2023-annual-report.pdf - Page 15 https://www.merck.com/content/dam/merck/investors/financials/2024-annual-report.pdf - Page 8 https://www.horizonblue.com/merck/securecms-documents/2509/2024-merck-flexible-spending-accounts-summary-plan-description.pdf - Page 22 https://www.horizonblue.com/merck/securecms-documents/2023/horizon-bcbs-merck-2023.pdf - Page 28 https://www.benefitsatmerck.com/wp-content/uploads/2023/03/MRK-2023-AE-mailer-L6a-032023-front-post-ltr.pdf - Page 20 https://www.merck.com/content/dam/merck/investors/financials/2022-annual-report.pdf - Page 14 https://www.merck.com/content/dam/merck/investors/financials/2023-annual-funding-notice.pdf - Page 17 https://www.merck.com/content/dam/merck/investors/financials/2024-annual-funding-notice.pdf - Page 23

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Merck employees